title: Corrections. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.
authors.forename: M
authors.initials: M
authors.lastname: Castro
authors.forename: J
authors.initials: J
authors.lastname: Zangrilli
authors.forename: M E
authors.initials: ME
authors.lastname: Wechsler